Key result
Circulating biomarkers enhance diagnosis, risk stratification, and prognosis across heart failure stages.
Why the study?
There is no ideal biomarker for heart failure, and current strategies rely on multiple biomarkers to improve risk stratification and predict HF-related death.
A multiple biomarker strategy incorporating natriuretic peptides, ST2, galectin-3, and troponins is important for risk stratification and personalized therapy in heart failure.
Answers are grounded in this paper and cite their sources.
May improve HF risk stratification via multi-biomarker panels; leaves open optimal combination validation in prospective studies.
Various biological markers are investigated as diagnostic and risk stratification tools for heart failure (HF). However, there is a large body of evidence that natriuretic peptides (NPs), solubilized ST2, galectin-3 and cardiac troponins have been demonstrated a significant relevance to HF advance and mortality rate. Because there is not only ideal biomarker current strategy of biomarker use in HF based on multiple biomarkers’ implementation to improve risk stratification and predict risk HF-related death. Consequently, understanding the mechanisms by which the biomarkers reflect several pathophysiological stages of HF is crucial for awareness of optimal personified therapy of different phenotypes of HF. Indeed, personalized risk prediction and nature evolution of HF based on biomarkers’ measure in HF patients remains to be challenged. The chapter is depicted the current role and future challenging of biological markers for evolution of HF development and progression. It has discussed the clinical guidelines reported by scientific societies with high levels of scientific reputation regarding HF therapies based on single and serial measurements of biological markers.
No takes yet. Share an insight, caveat, or question.
Alexander Е. Berezin (2018) conducted a review in Heart failure. Circulating biomarkers (natriuretic peptides, ST2, galectin-3, cardiac troponins) was evaluated. Circulating biomarkers, including natriuretic peptides, ST2, galectin-3, and cardiac troponins, play a crucial role in the diagnosis, risk stratification, and prognosis of heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: